4Crooke ST. Antisense strategies. Curr Mol Med, 2004. 4: 465-487.
5Surmacz E. Growth factor receptors as therapeutic targets: strategies to inhibit the insulin-like growth factor I receptor. Oncogene, 2003. 22:6589-6597.
6Scotlandi K. Maini C. Manara MC. et al. Effectiveness of insulin-like growth factor I receptor antisense Strategy against Ewing's sarcoma cells. Cancer Gene Ther. 2002. 9: 296-307.
7Bohula EA, Salisbury AJ. The efficacy of small interfering RNAs targeted to the type 1 insulin-like growth factor receptor (IGFIR) is influenced hy secondary structure in the IGFIR transcript. J Biol Chem, 20071. 278:15991-15997.
8Andrews DW, Resnicoff M, Fianders AE, et al. Results of a pilot study involving the use of an antisense oligodeoxynucleotide directed against the insulin-like growth factor type I receptor in malignant astrocytomas. J Clin Oncol, 2001, 19: 2189-2200.
9Surmacz E. Growth factor receptors as therapeutic targets: strategies to inhibit tile insulin-like growth factor I receptor. Oncogene, 2003. 22:6589-6597.
10Bahr C. Groner B, The insulin like growth factor-1 receptor (IGF-IR) as a drug target: novel approaches to cancer therapy. Growth Horm IGF Res, 200,14: 287-295.
